Markets all set for new life time highs in Expiry week

Markets continued their upward movement in the week after Diwali and gained on three of the four trading sessions. BSESENSEX gained 439.25 points or 1.01% to close at 43,882.25 points while NIFTY gained 139.10 points or 1.09% to close at 12,859.05 points. The one day of correction saw BSESENSEX lose more than the net gains of the week and was down 580 points while NIFTY lost 167 points. This is just to give a sense of the sharp correction that happened. The broader markets saw BSE100, BSE200 and BSE500 gain 1.13%, 1.44% and 1.57% respectively. BSEMIDCAP was up 3.53% while BSESMALLCAP gained 3.47%.

The Indian Rupee gained 44 paisa or 0.56% to close at Rs 74.16 to the US Dollar. Dow Jones lost 216.33 points or 0.73% to close at 29,263.48 points.

In primary market news, the issue from Gland Pharma Limited debuted on the bourses and had a decent showing. The company which had raised Rs 6,480 crs from a fresh issue of Rs 1,250 crs and an offer for sale of 3.48 cr shares at Rs 1,500 listed at Rs 1,701 on the BSE. The share closed at Rs 1,820.45 gaining Rs 320.45 or 21.36%. The company saw trading of almost 121 lac shares and 68.32 lac shares were delivered. The company would be closely monitored as there is a foreign holding cap of 75% and the company is quite close to it with the promoter post diluting being close to 58%. The remaining shares are largely held by various institutions, both domestic and Foreign and also retail individuals. The enforcement directorate also holds 60 lac shares, a shade over 3% belonging to the erstwhile promoters of Satyam Computer.

The week ahead sees November futures expire on Thursday the 26th of November. Currently the series is up 1,188.25 points or 10.18%. This is probably one of the best gains seen in any series over the last few months. With such an overpowering lead there is no way the bulls would like to allow the bears to claw back into the series. Over the last three weeks the series saw gains of 621 points, 456 points and 139 points on the NIFTY. On the BSESENSEX in the same period we saw gains of 2,279 points, 1,550 points and 439 points. In such a scenario it appears we are heading for a situation where the ensuing expiry day could lead to a culmination of the rally in the short and immediate term before a reasonable correction in terms of time and value sets in. If this were to happen which looks very likely, expect a sharp movement during the week and thereafter during the correction.

On the covid-19 front, the world saw 5,89,83,531 patients, 13,93,571 deaths and 4,07,65,521 people who have recovered. In India we saw 91,40,312 patients, 1,33,773 deaths and 85,61,444 people recovering. Compared to the previous week the world saw 38,54,427 new patients, 75,255 deaths and 28,94,146 people recovering. In India, we saw 3,25,320 new patients, 4,099 deaths and 3,55,716 people recovering. While the overall numbers for India show things improving, being a large country, we have pockets where things are out of control. Two such places are the national capital Delhi and Maharashtra’s 2nd largest city Pune. Other places include Ahmedabad and a few more cities in Gujarat.

The week ahead sees November futures expiring and a long weekend on account of a holiday on Monday the 30th of November. This extended weekend would ensure that there is large winding up of positions on Friday. Being the start of a new series, the same may start on a weak or a flattish note as we enter the last month of the calendar year 2020. Readers would recall that FII’s tend to take a Christmas and New Year break in the last week or fortnight of December and markets globally are quiet during this period, India included. This could be a good period for markets to consolidate and digest the sharp gains of the current month.

It therefore makes sense to book profits in any meaningful rally which happens in the coming four days and wait for markets to cool off, and correct in the following month before making any fresh purchases.

Gland Pharma Limited Debuts with gains of over 21%

Gland Pharma Limited debuted on the bourses on Friday the 20th November and had a decent performance gaining over 21%. The company had tapped the capital markets with its fresh issue of Rs 1,250 crs and an offer for sale of 3,48,63,635 equity shares in a price band of Rs 1,490-1500. Earlier the company had allotted 1,29,59,089 shares to 70 anchor investors comprising of 131 entities. The highest allocation was made to Smallcap World Fund who was allotted 8,57,400 shares or 6.62% of the anchor allotment. This was followed by 6,84,300 shares or 5.32% to Government of Singapore.

The issue was open from Monday the 9th of November to Wednesday the 11th of November.

The issue saw QIB’s subscribing the QIB portion 6.4 times. HNI portion was undersubscribed at 0.51 times while Retail portion remained undersubscribed at 0.24 times. There were just under 2 lac applications and the average application size was 1.8 lots or roughly 18 shares.

There was no funding in this issue for the HNI considering the highly fluctuating premium in the grey markets and the fact that HNI interest was likely to be lukewarm as it finally turned out to be.

The discovered price was Rs 1,701 on BSE and Rs 1,710 on NSE. At this price, 78,021 shares were traded on BSE and 24,63,249 shares were traded on NSE. The high of the day was Rs 1,850 on both the exchanges. The low was the open of Rs 1,701 on BSE while it was Rs 1,700 on NSE. The closing price was Rs 1,820.45 a gain of Rs 320.45 or 21.36% on BSE. The closing price on NSE was Rs 1,819.55, a gain of Rs 319.55 or 21.30%.

Exchange Open High Low Close Net Change % Gain/ Loss Wt.Avg Volume Delivery Del %age
BSE 1701.00 1850.00 1701.00 1820.45 320.45 21.36 1777.61 787955 470100 59.66
NSE 1710.00 1850.00 1700.00 1819.55 319.55 21.30 1765.57 11310647 6362366 56.25
Total 12098602 6832466 56.47

The traded volume on the two exchanges combined was 120.98 lac shares which was 28% of the IPO size of 431.97 lac shares and 40% of the non-anchor portion of 302.37 lac shares. Delivery volume was 68.32 lac shares which was 59.66% of the traded volume. It was 15.82% of the IPO size and 22.60% of the non-anchor portion. The weighted average of the day’s trade was Rs 1,777.61 on BSE while it was Rs 1,765.57 on NSE.

The company would be closely monitored as there is a foreign holding cap of 75% and the company is quite close to it with the promoter post diluting being close to 58%. The remaining shares are largely held by various institutions, both domestic and Foreign and also retail individuals. The enforcement directorate also holds 60 lac shares, a shade over 3% belonging to the erstwhile promoters of Satyam Computer.

It would be interesting to see what happens if the ED decided to sell the shares.

In conclusion, the listing of Gland Pharma has been far better than the general consensus was. The counter would be closely monitored in the coming days.

Performance of Newly Listed Shares as on 20th November

Name Date of Listing Issue Price Closing Price Closing Price % Gain Loss % Change Over
      201120 131120 Over Week lssue Price
Ujjivan Small Finance Bank Limited 12th December 37.00 33.70 33.05 1.97 -8.92
Prince Pipes and Fittings Limited 30th December 178.00 262.70 262.85 -0.06 47.58
SBI Card & Payment Services Limited 16th March 755.00 806.85 773.85 4.26 6.87
Rossari Biotech Limited 23rd July 425.00 788.95 765.50 3.06 85.64
Mindspace Buisness Parks Reit 7th July 275.00 305.27 305.27 0.00 11.01
Happiest Mind Technologies Ltd 17th September 166.00 320.30 321.30 -0.31 92.95
Route Mobile Limited 21st September 350.00 993.10 918.70 8.10 183.74
CAMS Limited 1st October 1230.00 1388.80 1300.60 6.78 12.91
Chemcon Speciality Chemicals Limited 1st October 340.00 418.25 418.40 -0.04 23.01
Angel Broking Limited 5th October 306.00 358.95 352.15 1.93 17.30
Mazazgon Dock Shipbuilders Limited 12th October 145.00 184.45 183.10 0.74 27.21
UTI AMC Limited 12th October 554.00 492.05 487.15 1.01 -11.18
Likhitha Infrastructure Limited 15th October 120.00 155.05 157.75 -1.71 29.21
Equitas Small Finance Bank Limited 2nd November 33.00 33.10 34.50 -4.06 0.30
Gland Pharma Limited 20th November 1500.00 1820.45 NA 21.36 21.36
Subscribe to RSS Feed Follow me on Twitter!